ScreverOncology Compass: Navigating the Fight Against Cancer
Cancer remains one of the most pressing challenges the modern medicine faces today. Oncologists, researchers, and healthcare professionals (HCPs) around the globe are on the front lines, tirelessly working to understand the disease, develop treatments, and improve patient outcomes.
However, many HCPs struggle to access the latest and most important research and treatment insights, especially in remote or resource-limited settings. This information gap is increased by the sheer volume of published studies and the difficulty distinguishing groundbreaking findings from general data.
Recognizing this challenge, we designed and launched Oncology Compass. Born as a local initiative for Swiss oncologists, it has since grown into a global platform to empower HCPs in the fight against cancer. Co-created by Capptoo and a major pharmaceutical company in Switzerland, Oncology Compass became fully independent in 2022, with Capptoo assuming sole ownership.
Its mission is simple: gather and provide the latest practice-changing cancer research results in one place, making them accessible to HCPs worldwide.
What is Oncology Compass?
Oncology Compass is an online platform that provides curated, practice-relevant publications and congress updates across 10 major cancer types. With a global subscriber base, it is a trusted resource for oncologists and other cancer specialists who seek actionable insights in their daily practice.
Key Features:
- Curated Content: A dedicated team of seventeen experienced medical specialists and renowned key opinion leaders in oncology reviews and selects studies, treatment papers, and articles from leading medical journals and congresses. This team ensures that only the most relevant and impactful information reaches our users.
- Medical Writing Expertise: Professional medical writers review and craft content tailored for HCPs, ensuring clarity and accuracy.
- Filtering Tools: Users can filter content by clinical characteristics, making it easier to pinpoint the publications that matter most to their specific cases.
- Quarterly Digests: Regular updates inform subscribers about the latest cancer research and treatment advancements.
A Global Resource for Cancer Care
Oncology Compass focuses on 10 cancer indications, including:
- Non-Small Cell Lung Cancer (NSCLC)
- Gastric Cancer
- Multiple Myeloma
- Esophageal Cancer
- Renal Cell Carcinoma
- Prostate Cancer
- Mesothelioma
- Small Cell Lung Cancer (SCLC)
- Melanoma
- Triple-Negative Breast Cancer (TNBC)
Currently, the platform hosts 831 practice-changing publications, all meticulously reviewed by our scientific board before being made available. The availability of these publications ensures that HCPs, regardless of location, have access to the most reliable and impactful research.
Testimonials from the Front Lines
Feedback from early adopters underscores the value of the Oncology Compass:
“In the vast sea of oncology research, Oncology Compass has become my anchor. It saves time and provides clarity, ensuring I’m always up to date with the most important advancements.”
“The filtering tool is a game changer. Finding the right study for my patient’s case has never been easier.”
These testimonials reflect our commitment to creating a platform that delivers information and empowers HCPs to act on it effectively.
Bridging the Gap in Cancer Care
Capptoo built the Oncology Compass platform with a clear goal: to close the gap between groundbreaking cancer research and the healthcare professionals who need it most.
By making vital information accessible and actionable, Oncology Compass is a significant asset in the ongoing effort to elevate the global cancer care standard.
Whether in a state-of-the-art hospital or a remote clinic, HCPs can rely on Oncology Compass as a refined and reliable tool in their fight against cancer.
